Newswire

Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare

Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?

Pharmacy middlemen claim to keep prescription prices low. In fact, they’ve cost consumers billions

Insurers, employers see payoffs switching to smaller PBMs

3Axis Report Scrutinizes PBM Spread Pricing Practice

Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update

Are below cost reimbursement practices by Pharmacy Benefit Managers creating opportunity for criminals to enter the legitimate supply chain?

As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

New reports detail UnitedHealth's latest acquisitions under shady pretenses

The Albatross Around America’s Neck: How health-care opacity neutralizes competition and fuels a corporate race to corner health-care markets

Strange bedfellows agree: PBM pricing reform cannot stop at Medicare, Medicaid

Local pharmacy owner, patient share concerns over relationships between PBMs and insurance companies

1 big thing: Employers in the dark

Small Business Needs PBM Reform Now

Have You Been Overcharged for Prescription Drugs? We Want to Hear From You.

NACDS unveils new spot on PBM reform

NYC Transit Retirees WIN Important Battle Against Medicare Advantage Push

Reforming PBM Practices Would Improve The Pharmacy Market